Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Connie Sanchéz, Karen E. Asin, Francesc Artigas
Pharmacology & Therapeutics (2014) Vol. 145, pp. 43-57
Open Access | Times Cited: 459

Showing 1-25 of 459 citing articles:

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Gin S. Malhi, Darryl Bassett, Philip Boyce, et al.
Australian & New Zealand Journal of Psychiatry (2015) Vol. 49, Iss. 12, pp. 1087-1206
Closed Access | Times Cited: 725
<p>Cognitive impairment in depression: recent advances and novel treatments</p>
Giulia Perini, Matteo Cotta Ramusino, Elena Sinforiani, et al.
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 1249-1258
Open Access | Times Cited: 284
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
Atul R. Mahableshwarkar, John Zajecka, W. Jacobson, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 8, pp. 2025-2037
Open Access | Times Cited: 283
The serotonergic system and cognitive function
Dubravka Švob Štrac, Nela Pivac, Dorotea Mück‐Šeler
Translational Neuroscience (2016) Vol. 7, Iss. 1, pp. 35-49
Open Access | Times Cited: 239
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Elena Dale, Benny Bang‐Andersen, Connie Sanchéz
Biochemical Pharmacology (2015) Vol. 95, Iss. 2, pp. 81-97
Open Access | Times Cited: 214
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 202
Monoaminergic system and depression
Laura Pérez-Caballero, Sonia Torres-Sánchez, Cristina Romero-López-Alberca, et al.
Cell and Tissue Research (2019) Vol. 377, Iss. 1, pp. 107-113
Closed Access | Times Cited: 156
Central 5-HT receptors and their function; present and future
Trevor Sharp, Nicholas M. Barnes
Neuropharmacology (2020) Vol. 177, pp. 108155-108155
Open Access | Times Cited: 156
Vortioxetine-associated syndrome of inappropriate ADH secretion
Sreedevi Sugunan, K.P. Lakshmi, Bindu Menon
BMJ Case Reports (2025) Vol. 18, Iss. 2, pp. e262735-e262735
Closed Access | Times Cited: 1
The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials
R. McIntyre, John Harrison, Henrik Loft, et al.
The International Journal of Neuropsychopharmacology (2016) Vol. 19, Iss. 10, pp. pyw055-pyw055
Open Access | Times Cited: 159
The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies
David S. Baldwin, Lambros Chrones, Ioana Florea, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 3, pp. 242-252
Open Access | Times Cited: 154
Serotonin receptors in depression and anxiety: Insights from animal studies
Elżbieta Żmudzka, Kinga Sałaciak, Jacek Sapa, et al.
Life Sciences (2018) Vol. 210, pp. 106-124
Closed Access | Times Cited: 152
Vortioxetine: Clinical Pharmacokinetics and Drug Interactions
Grace Chen, Astrid‐Maria Højer, Johan Areberg, et al.
Clinical Pharmacokinetics (2017) Vol. 57, Iss. 6, pp. 673-686
Open Access | Times Cited: 136
Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function
Elena Dale, Alan L. Pehrson, Theepica Jeyarajah, et al.
CNS Spectrums (2015) Vol. 21, Iss. 2, pp. 143-161
Open Access | Times Cited: 131
The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants
Stephan Köhler, Katharina Cierpinsky, Golo Kronenberg, et al.
Journal of Psychopharmacology (2015) Vol. 30, Iss. 1, pp. 13-22
Closed Access | Times Cited: 128
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
Mark J. Millan, Guy M. Goodwin, Andreas Meyer‐Lindenberg, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 5, pp. 599-656
Closed Access | Times Cited: 125
A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder
Bernhard T. Baune, Mélanie Brignone, Klaus Groes Larsen
The International Journal of Neuropsychopharmacology (2017) Vol. 21, Iss. 2, pp. 97-107
Open Access | Times Cited: 120
Laminar and Cellular Distribution of Monoamine Receptors in Rat Medial Prefrontal Cortex
Noemí Santana, Francesc Artigas
Frontiers in Neuroanatomy (2017) Vol. 11
Open Access | Times Cited: 118
Prefrontal cortex executive processes affected by stress in health and disease
Milena Girotti, Samantha M. Adler, Sarah E. Bulin, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 85, pp. 161-179
Open Access | Times Cited: 116
Molecular aspects of depression: A review from neurobiology to treatment
Gustavo Roberto Villas Boas, Roseli Boerngen de Lacerda, Marina Meirelles Paes, et al.
European Journal of Pharmacology (2019) Vol. 851, pp. 99-121
Closed Access | Times Cited: 112
Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction
Paula L. Jacobsen, Atul R. Mahableshwarkar, Y. Chen, et al.
The Journal of Sexual Medicine (2015) Vol. 12, Iss. 10, pp. 2036-2048
Closed Access | Times Cited: 108
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive Disorder
Paula L. Jacobsen, Atul R. Mahableshwarkar, Michael Serenko, et al.
The Journal of Clinical Psychiatry (2015) Vol. 76, Iss. 05, pp. 575-582
Open Access | Times Cited: 106
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
George I. Papakostas, D. Ionescu
Molecular Psychiatry (2015) Vol. 20, Iss. 10, pp. 1142-1150
Open Access | Times Cited: 102
Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant Vortioxetine
Steven C. Leiser, Yan Li, Alan L. Pehrson, et al.
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 7, pp. 970-986
Open Access | Times Cited: 101
Psychiatric disorders and sexual dysfunction
Marcel D. Waldinger
Handbook of clinical neurology (2015), pp. 469-489
Closed Access | Times Cited: 100
Page 1 - Next Page

Scroll to top